This pointed to a robust anti-viral response only in COVID-19 patients at D1 which was substantially muted by D7, as represented by the temporal expression patterns of key antiviral and interferon-related genes such as OAS2 and IFIT1 (Figure 5B). The gene discussed is OAS2; the disease is COVID-19.